Bempedoic acid is a first-in-class, oral adenosine triphosphate-citrate lyase (ACL) inhibitor used in the treatment of hypercholesterolemia to reduce low-density lipoprotein cholesterol levels. As a prodrug,… Read more


















































Bempedoic acid is a first-in-class, oral adenosine triphosphate-citrate lyase (ACL) inhibitor used in the treatment of hypercholesterolemia to reduce low-density lipoprotein cholesterol levels. As a prodrug, it undergoes hepatic activation to inhibit cholesterol biosynthesis, providing a therapeutic option for patients who require additional LDL-C lowering, particularly those intolerant to statins. Within this category, laboratories utilize high-quality reference standards, including the active pharmaceutical ingredient, to ensure accurate identification, potency, and purity assessments. Impurity profiling is supported by a comprehensive range of synthetic intermediates, degradation products, and process-related compounds, which are essential for analytical method validation and regulatory compliance. Furthermore, stable isotope labelled compounds are available to serve as internal standards for precision in mass spectrometry-based bioanalytical studies. These well-characterized materials enable pharmaceutical researchers to conduct rigorous quality control and stability testing in accordance with established pharmacopeial guidelines.